The gastrointestinal stromal tumor (GIST) market is expected to expand significantly by 2036, driven by advances in molecular diagnostics, targeted therapies, and mutation-specific treatments. Key therapies like ripretinib and avapritinib are gaining traction, while new drugs such as bezuclastinib and velzatinib are in late-stage development to address resistance and improve outcomes. The market growth is supported by improved diagnosis, regulatory incentives, and a growing pipeline focused on precision oncology. This evolution offers better treatment options for patients and strategic opportunities for pharmaceutical companies.
The gastrointestinal stromal tumor (GIST) market outlook is presented here with Pluang's Health-sector data for context. Of 150 priced Health-sector US stocks tradable on Pluang, 98 rose and 44 fell today. Notable movers include ARWR at USD 59.44 with a 1-day change of +2.25%, DNA at USD 12.02 with +2.21%, and CGC at USD 0.78 with +1.98%. This snapshot is as of Oct 14, 2026 17:11 WIB.
CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...
Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...
Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...
DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...
Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...
